| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000040092 |
| Receipt No. | R000045699 |
| Scientific Title | A Preliminary Randomized Controlled Trial Examining the Effects of Rumination Focused Cognitive Behavioral Therapy on Autism Spectrum Disorder and their Brain Basis |
| Date of disclosure of the study information | 2020/04/15 |
| Last modified on | 2020/10/06 (Ver. 2) |
| Basic information | ||
| Public title | A Preliminary Randomized Controlled Trial Examining the Effects of Rumination Focused Cognitive Behavioral Therapy on Autism Spectrum Disorder and their Brain Basis | |
| Acronym | Rumination Focused Cognitive Behavioral Therapy for Autism Spectrum Disorder | |
| Scientific Title | A Preliminary Randomized Controlled Trial Examining the Effects of Rumination Focused Cognitive Behavioral Therapy on Autism Spectrum Disorder and their Brain Basis | |
| Scientific Title:Acronym | A Preliminary Randomized Controlled Trial Examining the Effects of Rumination Focused Cognitive Behavioral Therapy on Autism Spectrum Disorder and their Brain Basis | |
| Region |
|
|
| Condition | ||
| Condition | Autism Spectrum Disorder | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The current preliminary randomized controlled trial aimed to test effect of rumination focused cognitive behavioral therapy (RFCBT) in adults with autism spectrum disorder (ASD) and comorbid depressive symptoms, and aimed to explore neural correlates of the comorbid depressive symptoms and the recovery from them in the participants with ASD. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase I,II |
| Assessment | |
| Primary outcomes | Changes in the Hamilton Depression Rating Scale (HDRS) 17-item version between baseline and endpoint. |
| Key secondary outcomes | 1. Resting state functional Magnetic Resonance Image(rs-fMRI)
2. Magnetic Resonance Image structure imag:T1- and T2-weighted images 3. Proton magnetic resonance spectroscopy(1H-MRS) 4. Beck Depression Inventory(BDI) 5. Ruminative Responses Scale(RRS) 6. State-Trait Anxiety Inventory(STAI) 7. Autism Spectrum Quotient-Japan(AQ-J) 8. Repetitive Behavior Scale-Revised(RBS-R) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Rumination Focused Cognitive Behavioral Therapy (RFCBT) including every week 12 one-hour sessions and treatment as usual | |
| Interventions/Control_2 | Treatment as usual | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Those who are 18 years old or older and under 50 years old at the time of obtaining consent.
2) Diagnosis of autism spectrum disorder based on Diagnostic and Statistical Manual of Mental Disorders-V(DSM-5)with score exceeding the cut-off value of Autism Diagnostic Observation Schedule Second Edition(ADOS-2)or Autism Diagnostic Interview-Revised(ADI-R). 3) Full Intelligent quotient above 80. 4) Hamilton Depression Rating Scale:(HDRS)score as 8 or more. 5) Applicants who have been given sufficient explanations to participate in this study and who have given their full understanding and consent in writing by themselves or their sponsors. |
|||
| Key exclusion criteria | 1) Those who have a high urgency for treatment, such as an imminent suicide attempt.
2) Patients with intracranial occupational lesions or vascular lesions such as cerebral infarction. 3) Patients with neurological diseases such as epilepsy. 4) MRI contraindicated. 5) Pregnancy or possible pregnancy. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hamamatsu University School of Medicine | ||||||
| Division name | Department of Psychiatry | ||||||
| Zip code | 431-3192 | ||||||
| Address | 1-20-1, Handayama, Higasi-ku, Hamamatsu city, Shizuoka, 431-3192, Japan. | ||||||
| TEL | 053-435-2295 | ||||||
| yamasue@hama-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hamamatsu University School of Medicine | ||||||
| Division name | Department of Psychiatry | ||||||
| Zip code | 431-3192 | ||||||
| Address | 1-20-1, Handayama, Higasi-ku, Hamamatsu city, Shizuoka, 431-3192, Japan. | ||||||
| TEL | 053-435-2295 | ||||||
| Homepage URL | |||||||
| 41310482@hama-med.ac.jp | |||||||
| Sponsor | |
| Institute | Hamamatsu University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grant-in-Aid for Scientific Research (KAKENHI) |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hamamatsu University school of medicine |
| Address | 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan |
| Tel | 053-435-2295 |
| rinri@hama-med.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045699 |